Concepedia
Statistics
Publications
10
Citations
207
H-Index
Active since
2018
Affiliations
Huazhong University of Science and Technology(Current)
Tongji Hospital
Chinese Academy of Medical Sciences & Peking Union Medical College
Renmin Hospital of Wuhan University
Ministry of Education of the People's Republic of China
Zhimiao Zou is an author at Huazhong University of Science and Technology specializing in medicine, immunology, and inflammation.
Top concepts
MedicineImmunologyInflammationPathologyCell DeathPharmacologyCell SignalingLupusHepatologyAutoimmunity
Publications per year
2018–2024
A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro
Jianhua Liu, Long He, Zhimiao Zou et al. · Kidney & Blood Pressure Research · 2018 · 32 citations · Full text
Liraglutide attenuates intestinal ischemia/reperfusion injury via NF-κB and PI3K/Akt pathways in mice
Zhimiao Zou, Zhiheng Wang · Life Sciences · 2022 · 31 citations
Inflammation, Pi3k/akt Pathways, Anti-inflammatory +9
The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3β and MyD88/NF-κB signalling pathways
Jianhua Liu, Chuang Chen, Zeyang Li et al. · Experimental Cell Research · 2020 · 22 citations
Tumor Biology, Signaling Pathway, Cell Regulation +15
Inhibition of MyD88 by a novel inhibitor reverses two-thirds of the infarct area in myocardial ischemia and reperfusion injury.
Miao Yan, Zuochuan Ding, Zhimiao Zou et al. · PubMed · 2020 · 21 citations · Full text
Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice
Zuochuan Ding, Dunfeng Du, Yang Yang et al. · International Immunopharmacology · 2018 · 20 citations
Inflammation, Hepatology, Medicine +11
1–5 of 10